GlassScriptPhysician profile
Rano Faltas
NPI 1992060891
$9,047.12
in general payments reported to CMS, 2019-2025
29 companies · $618 in 2025
The $618 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $366 · 2021: $1,356 · 2022: $2,142 · 2023: $1,483 · 2024: $2,244 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,208 · Travel and Lodging: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,208.35 |
| Travel and Lodging | $136.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,572.50 | 2019-2025 | Proclaim |
| Relievant Medsystems, INC. | $900.49 | 2022-2023 | Intracept |
| Boston Scientific Corporation | $838.00 | 2020-2025 | Superion Indirect Decompression System, Intracept, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $820.33 | 2019-2024 | Senza |
| Medtronic, INC. | $743.05 | 2023-2025 | Intellis Adaptivestim, Venaseal |
| Spr Therapeutics, INC | $642.69 | 2022-2025 | Sprint Pns System |
| Stryker Corporation | $528.98 | 2019 | |
| Saluda Medical Americas, INC. | $435.79 | 2022-2025 | Evoke Scs, Evoke |
| Si-Bone, INC. | $337.45 | 2022-2024 | |
| Biotronik Nro, INC. | $275.95 | 2025 | Prospera |
| Teva Pharmaceuticals USA, INC. | $144.55 | 2020-2025 | Austedo Xr, Austedo, Austedo Xr |
| Curonix LLC | $105.31 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lundbeck LLC | $87.65 | 2020-2023 | Vyepti |
| Collegium Pharmaceutical, INC. | $64.41 | 2020-2025 | Belbuca |
| Flowonix Medical Incorporated | $58.29 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $53.54 | 2024 | Mild Device Kit |
| Bioventus LLC | $53.13 | 2019-2021 | |
| Medtronic USA, INC. | $51.63 | 2019-2020 | |
| Abbvie INC. | $51.10 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $50.58 | 2021-2023 | Euflexxa |
| Stimwave Technologies Incorporated | $49.34 | 2020-2022 | |
| Nalu Medical, INC. | $38.03 | 2021-2024 | Nalu Neurostimulation System |
| Pfizer INC. | $29.65 | 2023-2025 | |
| Almatica Pharma LLC | $25.40 | 2022 | |
| Fidia Pharma USA INC. | $22.63 | 2024 | Hymovis |
| Biohaven Pharmaceuticals, INC. | $21.63 | 2021 | |
| Amgen INC. | $19.13 | 2022 | |
| Electronic Waveform Lab, INC. | $14.76 | 2019 | |
| Lilly USA, LLC | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rano Faltas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.